Wingspan Adds eREG Solution to Life Sciences Platform
Debuts Solution for Regulatory Submission Management
PHILADELPHIA, PA. - Wingspan Technology, the leading provider of content management solutions for life sciences, announced the release of Wingspan eREG, the newest edition to their Life Sciences Solution. Wingspan eREG is a cloud-based software solution for managing documents included in regulatory submissions and related documents. Wingspan eREG is built on the same user-friendly platform as Wingspan eTMF, providing intuitive user dashboards to provide transparency, insight, and accountability into the status of documents needed for upcoming submissions. Wingspan eREG provides streamlined processes for creation and approval of submission content, re-use of non-product specific documents such as excipients in multiple products, and support for submission assembly and publishing, including submission-ready PDFs. “We are happy to add Wingspan eREG to our complete, consistent, compliant platform for life sciences,” said Troy Deck, CEO of Wingspan Technology. “By applying the industry-leading technology of Wingspan eTMF to regulatory documentation, we are able to provide our customers with an easy way to manage and execute on the highly detailed regulatory process.” Wingspan will host a live demonstration of the new product in its “
Introducing Wingspan eREG
” webinar on July 26. In addition to Wingspan eREG, the Wingspan Life Sciences Solution also includes other cloud-based solutions – Wingspan eTMF and SiteZone, a site document exchange, offering customers a complete and integrated platform to drive efficiencies into the drug or device development process.
About Wingspan Technology, Inc.
Wingspan Technology, Inc. is the leading provider of life sciences and eClinical software solutions, including Wingspan eTMF and DocWay, the SharePoint/Documentum integration product suite. Wingspan's talented and knowledgeable engineering and project management teams offer in-depth industry knowledge and experience to companies in life sciences, pharmaceutical, financial services, and other fields.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
